Published: September 02, 2010
Shanghai SynTheAll Pharmaceuticals Co., Ltd. (STA) Receives ISO 14001 Certification
SHANGHAI , Sept. 3 /PRNewswire-Asia/ -- WuXi PharmaTech (NYSE: WX), a
leading pharmaceutical, biotechnology and medical device research and
development outsourcing company with operations in China and the United States ,
announced today that its manufacturing subsidiary, Shanghai SynTheAll
Pharmaceuticals Co. Ltd. (STA) passed the ISO 14001: 2004 inspection conducted
by SGS Group on July 1 and received formal ISO 14001 certification on July 30.
(Logo: http://www.newscom.com/cgi-bin/prnh/20040705/CNM002LOGO )
SGS Group is an inspection, verification, testing, and certification
company. The International Organization for Standardization (ISO) is the
world's largest developer and publisher of International Standards. ISO 14001
certification relates specifically to environmental management. Receiving ISO
14001 certification issued by SGS Group is a testimony to the well-organized,
well-conducted, and well-documented environmental practice at STA in areas
such as wastewater management, air emissions, and organic waste disposal.
"As a result of an extensive on-site evaluation, SGS Group certified that
this facility meets the highest international standards of environmental
practice and on-site management," said Dr. Weimin Chang, Vice President of
Operations and General Manager of STA. "As STA is now certified by SGS Group
for ISO 9001 for quality management as well as for ISO 14001 for environmental
management, we are confident that STA will pass environmental health and
safety audits from our customers and government agencies. The staff at STA
considers environment protection to be a social responsibility. We spare no
effort to save energy, cut emissions, and implement practices for sustainable
development while providing our customers with the highest quality of
service."
For more information, please contact:
Ronald Aldridge (for investors)
Tel: +1-201-585-2048
Email: Ron_Aldridge@wuxiapptec.com
Stephanie Liu (for the media)
Tel: +86-21-5046-4362
Email: pr@wuxiapptec.com
SOURCE WuXi PharmaTech
Copyright © 2012, PRNewswire
Copyright © 2012, NewsBlaze,
Daily News